These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report. Tolentino JG; Rodriquez JN; Abalos RM Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924 [No Abstract] [Full Text] [Related]
26. A study of skin pigmentation by clofazimine. Levy L; Randall HP Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493 [No Abstract] [Full Text] [Related]
27. A study of clofazimine in the rat. Currey HL; Fowler PD Br J Pharmacol; 1972 Aug; 45(4):676-81. PubMed ID: 5085241 [TBL] [Abstract][Full Text] [Related]
28. Therapy of leprosy. Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; MartÃnez DomÃnguez V Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056 [TBL] [Abstract][Full Text] [Related]
29. Treatment of leprosy with Lampren (B.663 Geigy). De las Aguas JT Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089 [No Abstract] [Full Text] [Related]
30. Story behind the clinical trial of B.663 in leprosy. Chang YT Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040 [No Abstract] [Full Text] [Related]
31. [Lampren in the treatment of leprosy]. Ahrens T Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711 [No Abstract] [Full Text] [Related]
32. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy. Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715 [No Abstract] [Full Text] [Related]
33. New drug for leprosy. Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074 [No Abstract] [Full Text] [Related]
34. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]
35. Clofazimine: current status and future prospects. Cholo MC; Steel HC; Fourie PB; Germishuizen WA; Anderson R J Antimicrob Chemother; 2012 Feb; 67(2):290-8. PubMed ID: 22020137 [TBL] [Abstract][Full Text] [Related]
36. Activity of phenazine analogs against Mycobacterium leprae infections in mice. Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439 [TBL] [Abstract][Full Text] [Related]
37. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage. Naafs B Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120 [No Abstract] [Full Text] [Related]